BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 263 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $231,000 | +17.9% | 2,227 | 0.0% | 0.01% | +33.3% |
Q2 2021 | $196,000 | -10.1% | 2,227 | -0.8% | 0.01% | -18.2% |
Q1 2021 | $218,000 | +84.7% | 2,246 | +75.7% | 0.01% | +37.5% |
Q3 2020 | $118,000 | +61.6% | 1,278 | +39.2% | 0.01% | +60.0% |
Q2 2020 | $73,000 | +630.0% | 918 | +440.0% | 0.01% | +400.0% |
Q1 2020 | $10,000 | – | 170 | +8400.0% | 0.00% | – |
Q4 2019 | $0 | -100.0% | 2 | -97.9% | 0.00% | – |
Q3 2019 | $7,000 | -22.2% | 94 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $9,000 | +12.5% | 94 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $8,000 | +60.0% | 94 | 0.0% | 0.00% | – |
Q4 2018 | $5,000 | -28.6% | 94 | 0.0% | 0.00% | -100.0% |
Q3 2018 | $7,000 | -100.0% | 94 | -68.8% | 0.00% | -50.0% |
Q2 2018 | $19,108,000 | +79516.7% | 301 | +16.2% | 0.00% | 0.0% |
Q1 2018 | $24,000 | +33.3% | 259 | +13.1% | 0.00% | 0.0% |
Q4 2017 | $18,000 | +500.0% | 229 | +377.1% | 0.00% | – |
Q3 2017 | $3,000 | +50.0% | 48 | +11.6% | 0.00% | – |
Q2 2017 | $2,000 | 0.0% | 43 | +13.2% | 0.00% | – |
Q1 2017 | $2,000 | – | 38 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |